Ocugen (OCGN) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free OCGN Stock Alerts $1.59 -0.08 (-4.79%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGNprnewswire.com - May 10 at 4:10 PMOcugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stockglobenewswire.com - May 10 at 4:05 PMOcugen to Present at May 2024 Investor Conferencesglobenewswire.com - May 10 at 7:45 AMMillionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028investorplace.com - May 8 at 6:00 AMOcugen (OCGN) to Release Earnings on Tuesdaymarketbeat.com - May 7 at 12:02 PMINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmstockhouse.com - May 6 at 4:15 PMONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenmarkets.businessinsider.com - May 5 at 7:11 PMOcugen to Unveil Q1 2024 Financials and Business Updates in Upcoming Callmsn.com - May 4 at 1:53 AMROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGNprnewswire.com - May 3 at 1:44 PMSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenprnewswire.com - May 3 at 9:45 AMOcugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Resultsfinance.yahoo.com - May 3 at 9:43 AMOcugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congressglobenewswire.com - May 2 at 7:15 AMIMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmprnewswire.com - May 1 at 10:15 AMLatest News for Ocugen Stock (NASDAQ:OCGN)benzinga.com - April 30 at 10:43 PMDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenmarkets.businessinsider.com - April 30 at 10:43 PMGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investorsbusinesswire.com - April 29 at 8:14 PMOcugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024markets.businessinsider.com - April 29 at 8:51 AMCan Ocugen Stock Keep Churning Higher?fool.com - April 29 at 8:30 AMOcugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024globenewswire.com - April 29 at 6:45 AMSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGNprnewswire.com - April 28 at 9:00 AMROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGNprnewswire.com - April 26 at 6:34 PMOcugen (OCGN) to Report Q1 Earnings: What's in the Cards?finance.yahoo.com - April 26 at 3:11 PMSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenmarkets.businessinsider.com - April 26 at 10:02 AMUPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meetingglobenewswire.com - April 26 at 9:05 AMOcugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meetingglobenewswire.com - April 26 at 6:30 AMIMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmprnewswire.com - April 23 at 11:30 AMOcugen (NASDAQ:OCGN) Given New $5.00 Price Target at Chardan Capitalmarketbeat.com - April 22 at 8:29 AMKey Takeaways From Ocugen Analyst Ratingsmarkets.businessinsider.com - April 22 at 8:19 AMSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenmarkets.businessinsider.com - April 21 at 10:14 AMSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGNprnewswire.com - April 20 at 11:00 AMOcugen: Two Gene Therapy Data Readouts In 2024 To Drive Valueseekingalpha.com - April 19 at 8:04 PMOCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!prnewswire.com - April 19 at 12:00 PMOcugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapyglobenewswire.com - April 19 at 7:13 AMOcugen stock jumps after $175M securities filingmsn.com - April 18 at 9:05 AMOcugen, Inc. (OCGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsstockhouse.com - April 18 at 12:44 AMROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGNprnewswire.com - April 17 at 11:00 PMINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmmarkets.businessinsider.com - April 17 at 2:44 PMIMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmprnewswire.com - April 17 at 1:51 PMOcugen (OCGN) Price Target Decreased by 15.79% to 5.44msn.com - April 17 at 9:43 AMOCGN Stock Earnings: Ocugen Beats EPS for Q4 2023msn.com - April 17 at 12:32 AM3 Standout Penny Stocks to Watch This Aprilmsn.com - April 16 at 2:32 PMShort Interest in Ocugen, Inc. (NASDAQ:OCGN) Grows By 22.8%marketbeat.com - April 15 at 5:09 PMSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmprnewswire.com - April 15 at 9:00 AMDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugenmarkets.businessinsider.com - April 14 at 9:29 AMOcugen CEO to Highlight Gene Therapy Advances at Healthcare Equity Conferencemsn.com - April 14 at 9:29 AMSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firmmarkets.businessinsider.com - April 12 at 7:26 PMINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investorsbusinesswire.com - April 12 at 1:51 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ocugen, Inc. - OCGNprnewswire.com - April 12 at 9:30 AMOcugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Marketsglobenewswire.com - April 12 at 7:30 AMEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Ocugen, Inc. Incorporated Investors - OCGNtmcnet.com - April 11 at 5:50 PM Get Ocugen News Delivered to You Automatically Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… OCGN Media Mentions By Week OCGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCGN News Sentiment▼0.410.58▲Average Medical News Sentiment OCGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCGN Articles This Week▼83▲OCGN Articles Average Week Get Ocugen News Delivered to You Automatically Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Solid Biosciences News SOPHiA GENETICS News Caribou Biosciences News Tenaya Therapeutics News Jasper Therapeutics News MeiraGTx News Aura Biosciences News TScan Therapeutics News Anavex Life Sciences News Adaptive Biotechnologies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCGN) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocugen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
